Patent US4455301A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4455301A Expired / Lapsed US ⏱️ 0.0 years remaining

Antihemophilic factor concentrate

Assignee: Bayer Corp
•
Filing: 1982-09-29
•
Granted: 1984-06-19
•
Expires: 2002-09-29
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel antihemophilic factor concentrates and process for making the same are disclosed. An aqueous solution of anithemophilic factor proteins is obtained, preferably by solubilizing antihemophilic factor proteins from blood plasma cryoprecipitate in water. The aqueous solution is purified to remove unwanted protein, for example, by mixing the aqueous solution with aluminum hydroxide. Then, the aqueous solution is ultrafiltered to concentrate it, mixed with buffer and saline and adjusted to an acid pH, and freeze-dried.

Inventors

  • 👤 Gautam Mitra
  • 👤 John L. Lundblad

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 20:55
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/745; C07K14/755; A; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 45 words
Antihemophilic factor concentrate containing Von Willebrandt factor (VIIIR:WF), procoagulant factor (VIII:C) and fibrinogen (φ) wherein the VIII:C/VIIIR:WF ratio is in the range of about 1/0.5-1 and wherein the ratio of procoagulant factor to milligrams of fibrinogen (VIII:C/mg φ) is in the range of about 2.6-4.0/1.
Claim 2
Dependent Claim 45 words
Antihemophilic factor concentrate containing Von Willebrandt factor (VIIIR:WF), procoagulant factor (VIII:C) and fibrinogen (φ) wherein the VIII:C/VIIIR:WF ratio is in the range of about 1/0.5-1 and wherein the ratio of procoagulant factor to milligrams of fibrinogen (VIII:C/mg φ) is in the range of about 2.6-4.0/1.
Claim 3
Dependent Claim 20 words
The product of claim 1 wherein the concentration of Von Willebrandt factor is about 15 units per milliliter or more.
Claim 4
Dependent Claim 18 words
The product of claim 1 wherein the ratio of Von Willebrandt factor to procoagulant factor is about 1/1.

References Cited (Backward Citations)

US4289691A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-06-19 1987-12-19 1988-06-19 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-06-19 1991-12-19 1992-06-19 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-06-19 1995-12-19 1996-06-19 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag